Ajaz Hussain

Dr. Ajaz Hussain is a distinguished contributor and acknowledged leader in the advancement of pharmaceuticals, regulatory science, and drug development. During Dr. Hussain's tenure at the FDA, as Deputy Director, Office of pharmaceutical Science, he led the FDA efforts on Process Analytical Technology (PAT) Initiative and CGMPs for the 21st Century. He was the FDA's lead for Quality ICH negotiations and the establishment of ICH initiative on pharmaceutical Quality for the 21st Century (ICH Q8, 09, and QIO). He has served as the president of the National Institute for pharmaceutical Technology & Education (a not-for-profit collaboration among leading American universities), as the principal of his consulting company Insight, Advice & Solutions. He has also held several senior management positions including CSO & president of Biotechnology at Wockhardt, Chief Scientific Officer at Philip Morris International, VP & Global Head of Biopharmaceutical Development at Sandoz, and Associate Professor of pharmaceutics at the University of Cincinnati's College of Pharmacy.